Sort
8,912 grants matching “sars cov 2”
CBT by Phone to Promote Use of Alcohol Related Care and Reduce Drinking
$149,552Kenneth R Conner · University Of Rochester · R01 · FY2021 · AA
Administrative Core
$149,506Monica Kraft · University Of Arizona · U19 · FY2025 · AI
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life (Supplement)
$149,165Stefano Guerra · University Of Arizona · R01 · FY2020 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization- Data Management and Analysis Core
$149,099Raphael Gottardo · Seattle Children'S Hospital · U19 · FY2024 · AI
Examining the Interplay of COVID-19 and HIV: Impacts on HIV Care, Disparities, and Long-Term Outcomes
$148,824McKaylee Robertson · Graduate School Of Public Health And Health Policy · K01 · FY2024 · AI
Examining the Interplay of COVID-19 and HIV: Impacts on HIV Care, and Long-Term Outcomes
$148,824McKaylee Robertson · Graduate School Of Public Health And Health Policy · K01 · FY2025 · AI
A Longitudinal Study of COVID-19 Sequelae and Immunity
$148,734Michael C Sneller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Targeting Functional RNA Elements in the SARS-CoV-2 Genome
$148,693John Schneekloth · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection
$148,678Fusataka Koide · Southern Research Institute · N01 · FY2021 · AI
Core D - Data Management and Bioinformatics Core
$148,452Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
RAPID:Genomic Variation Analysis of Coronavirus to Better Understand the Spread of COVID-19
$148,386Jing Li · Case Western Reserve University · · FY2020 · CSE
Cerebral vascular pathology of COVID-19
$148,376Michal J. Toborek · University Of Miami School Of Medicine · R01 · FY2022 · HL
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$147,657Mark R Denison · Vanderbilt University Medical Center · R01 · FY2022 · AI
Research Initiatives on COVID-19 in the Division of Translational Toxicology
$147,440Dori R Germolec · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Seroprevalence of COVID-19 of cancer patients in Tanzania
$147,415Charles Wood · University Of Nebraska Lincoln · U54 · FY2020 · CA
Characterization of host immune responses to SARS-CoV-2
$147,238Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19
$147,159John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
RAPID: A comparison of the 1918 influenza pandemic and COVID-19 in Missouri: implications for current mitigation strategies in rural versus urban locations
$146,794Lisa Sattenspiel · University Of Missouri-Columbia · · FY2020 · SBE
Alcohol and the alveolar epithelial barrier
$146,791Michael H. Koval · Emory University · R01 · FY2020 · AA
Administrative Core
$146,789Monica Kraft · University Of Arizona · U19 · FY2021 · AI
RAPID: Collaborative Research: Metapopulation Modeling to Develop Strategies to Reduce COVID-19 Transmission in Public Spaces
$146,711John J Dennehy · Cuny Queens College · · FY2020 · BIO
COVID-19 Healthcare Access and Sequelae Evaluation
$146,554Marc Kowalkowski · Carolinas Medical Center · R01 · FY2021 · NR
Characterization of host immune responses to SARS-CoV-2
$146,401Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
COVID-19 Healthcare Access and Sequelae Evaluation
$146,310Marc Kowalkowski · Carolinas Medical Center · R01 · FY2022 · NR
Antibody discovery
$146,225Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR